学会発表（国際）
Cardiovascular Risks Associated with Dipeptidyl-Peptidase 4 Inhibitor Compared to Other Diabetes Drugs: a Cohort Study
Komamine M, Ishiguro C, Takeuchi Y, Uyama Y. Cardiovascular Risks Associated with Dipeptidyl-Peptidase 4 Inhibitor Compared to Other Diabetes Drugs: a Cohort Study (poster presentation). 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management. Dublin. Aug 2016.
test